Hobson Brianna J, Lett Elle, Hawkins Linda A, Swendiman Robert A, Nance Michael L, Dowshen Nadia L
Institute for Graduate Clinical Psychology, Widener University, Chester, Pennsylvania, USA.
Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Transgend Health. 2022 Aug 1;7(4):364-368. doi: 10.1089/trgh.2021.0006. eCollection 2022 Aug.
This descriptive study reports caregiver experiences with GnRH agonist implants among a cohort of youth followed in a pediatric hospital-based gender clinic. We administered a survey to 36 of 55 eligible caregivers ascertaining demographics and satisfaction, with a medical record review of any surgical complications. The overwhelming majority (97.1%) reported satisfaction with the procedure and would undergo the implant procedure again (94.4%). The most frequent challenges noted were about affordability (39.8%) and insurance denials (39.8%). Implantable GnRH agonist can be used successfully in pediatric patients with gender dysphoria. Future policy should seek to address concerns regarding insurance approval and reimbursement.
这项描述性研究报告了在一家儿科医院性别诊所接受随访的一组青少年中,照顾者使用促性腺激素释放激素(GnRH)激动剂植入物的经历。我们对55名符合条件的照顾者中的36名进行了调查,以确定其人口统计学特征和满意度,并对任何手术并发症进行了病历审查。绝大多数(97.1%)报告对该手术满意,并愿意再次接受植入手术(94.4%)。指出的最常见挑战是费用可承受性(39.8%)和保险拒付(39.8%)。可植入的GnRH激动剂可成功用于患有性别焦虑症的儿科患者。未来的政策应设法解决有关保险批准和报销的问题。